Last viewed: VTRS


Prices are updated after-hours



nasdaq:VTRS Viatris Inc.

VTRS | News | $15.04 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (14.9% 1m) (-13.1% 1y) (0.0% 2d) (-0.9% 3d) (0.6% 7d) (NaN% volume)
http://www.viatris.com
Sec Filling | Patents | 35000 employees

Viatris, Inc. engages in the commercialization and manufacturing of pharmaceutical products. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.

add to today's watch list email alert is off




education   diagnostics  

Press-releases


Global Professional Acne Medication Market (2022 to 2030) - Opportunity Analysis and Industry Forecast
Published: 2022-01-19 (Crawled : 19:00) - prnewswire.com
JNJ | News | $167.165 | twitter stocktwits trandingview |
Health Technology
| | O: 0.06% H: 0.0% C: 0.0%
GSK | News | $45.96 | twitter stocktwits trandingview |
Health Technology
| | O: -1.78% H: 0.0% C: 0.0%
BHC | News | $25.58 | twitter stocktwits trandingview |
Health Technology
| | O: -4.51% H: 0.0% C: 0.0%

acne
Prils Market to grow at a CAGR of 5.43% by 2026 | Evolving Opportunities with Aurobindo Pharma Ltd. and Dr. Reddys Laboratories Ltd.|17000+ Technavio Reports
Published: 2022-01-19 (Crawled : 07:00) - prnewswire.com
NVS | News | $88.91 | twitter stocktwits trandingview |
Health Technology
| | O: -0.6% H: 0.0% C: 0.0%
VTRS | News | $15.04 | twitter stocktwits trandingview |
Health Technology
| | O: -0.86% H: 0.0% C: 0.0%

report
DNA Vaccine Market Size to Grow $774.43 Million, Globally, by 2030 at 6.3% CAGR: AMR
Published: 2022-01-18 (Crawled : 09:00) - prnewswire.com
VTRS | News | $15.04 | twitter stocktwits trandingview |
Health Technology
| | O: 1.47% H: 0.0% C: 0.0%
ZTS | News | $203.68 | twitter stocktwits trandingview |
Health Technology
| | O: -2.28% H: 0.0% C: 0.0%
GOVX | $2.64 | twitter stocktwits trandingview |
Health Technology
| | O: -4.29% H: 4.48% C: -0.75%

vaccine
Human Growth Hormone (hGH) Market to Reach $9.21 Billion, By 2030 at 9.0% CAGR: AMR
Published: 2022-01-14 (Crawled : 01:00) - prnewswire.com
VTRS | News | $15.04 | twitter stocktwits trandingview |
Health Technology
| | O: -1.64% H: 0.0% C: 0.0%
NVO | $97.08 | twitter stocktwits trandingview |
Health Technology
| | O: -3.67% H: 0.0% C: 0.0%
LLY | News | $245.05 | twitter stocktwits trandingview |
Health Technology
| | O: -1.46% H: 0.0% C: 0.0%
ABT | News | $126.83 | twitter stocktwits trandingview |
Health Technology
| | O: -1.54% H: 0.0% C: 0.0%

growth hormone growth hormone
Theravance Biopharma, Inc. Announces Enrollment of First Patient in YUPELRI® Phase 4 Study
Published: 2022-01-10 (Crawled : 12:00) - biospace.com/
VTRS | News | $15.04 | twitter stocktwits trandingview |
Health Technology
| | O: 1.58% H: 1.62% C: 1.62%


Viatris Wins Court Decisions on Sanofi Appeals of Lantus® Patent Invalidations
Published: 2021-12-30 (Crawled : 03:00) - prnewswire.com
VTRS | News | $15.04 | twitter stocktwits trandingview |
Health Technology
| | O: -0.37% H: 1.78% C: 0.3%
SNY | News 2 d | $51.79 | twitter stocktwits trandingview |
Health Technology
| | O: 0.08% H: 0.26% C: -0.2%

lantus als patent
Viatris to Move its Investor Event Previously Scheduled for January 7 to no Later Than February 28 When the Company Expects to Report its Fourth Quarter 2021 Results
Published: 2021-12-17 (Crawled : 23:00) - prnewswire.com
MYL | News | $15.86 | twitter stocktwits trandingview |
Health Technology

VTRS | News | $15.04 | twitter stocktwits trandingview |
Health Technology

results
Thyroid Gland Disorder Treatment Market Records a CAGR of 4.63% by 2025|35% of Growth to Originate from North America |17000+ Technavio Reports
Published: 2021-12-14 (Crawled : 12:30) - prnewswire.com
VTRS | News | $15.04 | twitter stocktwits trandingview |
Health Technology
| | O: -0.4% H: 4.78% C: 2.07%
GSK | News | $45.96 | twitter stocktwits trandingview |
Health Technology
| | O: -0.77% H: 0.6% C: 0.23%
ABBV | News | $136.48 | twitter stocktwits trandingview |
Health Technology
| | O: 0.49% H: 0.0% C: 0.0%
ABT | News | $126.83 | twitter stocktwits trandingview |
Health Technology
| | O: 0.75% H: 0.0% C: 0.0%
GLAXF | News | $22.5865 | twitter stocktwits trandingview |
Health Technology
| | O: -3.37% H: 0.0% C: 0.0%
AMGN | News | $233.74 | twitter stocktwits trandingview |
Health Technology
| | O: 0.22% H: 1.65% C: 1.15%

treatment order growth
Viatris Wins Federal Circuit Court Appeal Upholding District Court Decision Invalidating Biogen's Tecfidera® Patent
Published: 2021-12-01 (Crawled : 16:00) - biospace.com/
VTRS | News | $15.04 | twitter stocktwits trandingview |
Health Technology
| | O: 0.89% H: 0.89% C: -2.66%

patent dating
Viatris and Biocon Biologics Announce Launch of Interchangeable SEMGLEE® (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection
Published: 2021-11-16 (Crawled : 13:00) - biospace.com/
VTRS | News | $15.04 | twitter stocktwits trandingview |
Health Technology
| | O: -0.99% H: 0.14% C: -0.64%

injection insulin
See all


Last 15 days Sec forms
File Id Form Date Direction Code Amount Transacted Owned Amount
0000899243-21-026046 4 2021-06-25 Sell M 250000 0
0000899243-21-026046 4 2021-06-25 Sell F 123950 1509637
0000899243-21-026046 4 2021-06-25 Buy M 250000 1633587
0000899243-21-025632 4 2021-06-24 Buy A 155 155
0000899243-21-025632 4 2021-06-24 Buy A 215 215
0000899243-21-025632 4 2021-06-24 Buy A 108 108
0000899243-21-025632 4 2021-06-24 Buy A 49 49


Your Today's Watch List
Sign in to create a watchlist
Today's Insiders Buying

Yesterday's Insiders Buying